本页面由Tiger Trade Technology Pte. Ltd.提供服务

Genmab A/S

26.14
-0.4300-1.62%
盘后26.150.0100+0.04%17:19 EDT
成交量:103.27万
成交额:2,710.71万
市值:167.92亿
市盈率:17.01
高:26.84
开:26.61
低:26.06
收:26.57
52周最高:35.43
52周最低:17.24
股本:6.42亿
流通股本:6.35亿
量比:0.59
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):1.54
每股收益(LYR):1.54
净资产收益率:17.53%
总资产收益率:8.10%
市净率:2.87
市盈率(LYR):17.01

数据加载中...

公司资料

公司名字:
Genmab A/S
交易所:
NASDAQ
成立时间:
1998
员工人数:
2973
公司地址:
Carl Jacobsens Vej 30,Valby,Copenhagen,Capital Region of Denmark,Denmark
邮编:
2500
传真:
- -
简介:
Genmab A/S于1998年6月11日注册成立。该公司是一家国际生物技术公司,拥有一系列基于抗体的新型产品和候选产品,旨在满足癌症和其他严重疾病患者的医疗需求,并改善其治疗结果。公司建立其产品线的目标是在他们认为能够最大化其价值并对治疗领域产生有意义影响的地理区域,将药物推向市场。

董事

名称
职位
Deirdre P. Connelly
Chair of the Board and Independent Director
Elizabeth O'Farrell
Independent Director
Paolo Paoletti
Independent Director
Pernille Erenbjerg
Deputy Chair and Independent Director
Rolf Hoffmann
Independent Director
Anders Gersel Pedersen
Director
Martin Schultz
Director
Michael Kavanagh
Director
Mijke Zachariasse
Director

股东

名称
职位
Jan G. J. van de Winkel
Chief Executive Officer and President
Anthony Pagano
Executive Vice President and Chief Financial Officer
Brad Bailey
Chief Commercial Officer and Executive Vice President
Christopher Cozic
Chief People Officer and Executive Vice President
Greg Mueller
Executive Vice President,General Counsel & Chief Legal Officer
Judith Klimovsky
Chief Development Officer and Executive Vice President
Martine J. van Vugt
Chief Strategy Officer and Executive Vice President
Rayne Waller
Chief Technical Operations Officer and Executive Vice President
Tahamtan Ahmadi
Executive Vice President and Chief Medical Officer, Head of Experimental Medicines